61 162

Cited 0 times in

ZAG Regulates the Skin Barrier and Immunity in Atopic Dermatitis

DC Field Value Language
dc.contributor.author김태균-
dc.contributor.author노지연-
dc.contributor.author이광훈-
dc.date.accessioned2022-08-19T06:26:39Z-
dc.date.available2022-08-19T06:26:39Z-
dc.date.issued2019-08-
dc.identifier.issn0022-202X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/189175-
dc.description.abstractAdipokines modulate immune responses and lipid metabolism in allergic disease; however, little is known about their role in the skin barrier and atopic dermatitis (AD). We identified ZAG, an adipokine that regulates lipid mobilization, as a biomarker for AD. ZAG levels were consistently decreased in sera, T cells, and skin in human AD patients compared with healthy controls. ZAG was primarily detected in the stratum corneum along with FLG and LOR. Knockdown of ZAG with short hairpin RNA resulted in decreased FLG and increased TSLP. Topical ZAG treatment in AD mice recovered ZAG expression in the skin and improved AD-like symptoms, transepidermal water loss, and ceramide levels. Furthermore, topical ZAG treatment induced immunoregulatory effects, including reduction of IL-4, IL-17, and IFN-gamma and increased Foxp3 in the skin and lymphoid organs. Interestingly, ZAG treatment also recovered decreased levels of ADAM17, an important player in skin barrier function and immune response in AD. Thus, ZAG deficiency is closely related to skin barrier function and the immune abnormalities of AD, and we suggest that restoration of ZAG may be a promising therapeutic option for the treatment of AD.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfJOURNAL OF INVESTIGATIVE DERMATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHADAM17 Protein / immunology-
dc.subject.MESHADAM17 Protein / metabolism-
dc.subject.MESHAdipokines-
dc.subject.MESHAdministration, Topical-
dc.subject.MESHAnimals-
dc.subject.MESHBiomarkers / analysis-
dc.subject.MESHBiomarkers / metabolism-
dc.subject.MESHCarrier Proteins / administration & dosage-
dc.subject.MESHCarrier Proteins / genetics-
dc.subject.MESHCarrier Proteins / immunology*-
dc.subject.MESHCarrier Proteins / metabolism-
dc.subject.MESHCell Line-
dc.subject.MESHDermatitis, Atopic / diagnosis-
dc.subject.MESHDermatitis, Atopic / drug therapy-
dc.subject.MESHDermatitis, Atopic / immunology*-
dc.subject.MESHDermatitis, Atopic / pathology-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHFemale-
dc.subject.MESHFilaggrin Proteins-
dc.subject.MESHGlycoproteins / administration & dosage-
dc.subject.MESHGlycoproteins / genetics-
dc.subject.MESHGlycoproteins / immunology*-
dc.subject.MESHGlycoproteins / metabolism-
dc.subject.MESHHumans-
dc.subject.MESHInjections, Intradermal-
dc.subject.MESHKeratinocytes-
dc.subject.MESHLipid Metabolism / genetics-
dc.subject.MESHLipid Metabolism / immunology-
dc.subject.MESHMice-
dc.subject.MESHPermeability-
dc.subject.MESHRNA, Small Interfering / metabolism-
dc.subject.MESHRecombinant Proteins / administration & dosage-
dc.subject.MESHRecombinant Proteins / immunology-
dc.subject.MESHRecombinant Proteins / metabolism-
dc.subject.MESHSkin / immunology-
dc.subject.MESHSkin / metabolism-
dc.subject.MESHSkin / pathology*-
dc.subject.MESHT-Lymphocytes / immunology-
dc.subject.MESHT-Lymphocytes / metabolism-
dc.titleZAG Regulates the Skin Barrier and Immunity in Atopic Dermatitis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Dermatology (피부과학교실)-
dc.contributor.googleauthorJi Yeon Noh-
dc.contributor.googleauthorJung U Shin-
dc.contributor.googleauthorJi Hye Kim-
dc.contributor.googleauthorSeo Hyeong Kim-
dc.contributor.googleauthorBo-Mi Kim-
dc.contributor.googleauthorYoung Hwan Kim-
dc.contributor.googleauthorSemin Park-
dc.contributor.googleauthorTae-Gyun Kim-
dc.contributor.googleauthorKyong-Oh Shin-
dc.contributor.googleauthorKyungho Park-
dc.contributor.googleauthorKwang Hoon Lee-
dc.identifier.doi10.1016/j.jid.2019.01.023-
dc.contributor.localIdA05324-
dc.contributor.localIdA01296-
dc.contributor.localIdA02674-
dc.relation.journalcodeJ01469-
dc.identifier.eissn1523-1747-
dc.identifier.pmid30738053-
dc.contributor.alternativeNameKim, Tae-Gyun-
dc.contributor.affiliatedAuthor김태균-
dc.contributor.affiliatedAuthor노지연-
dc.contributor.affiliatedAuthor이광훈-
dc.citation.volume139-
dc.citation.number8-
dc.citation.startPage1648-
dc.citation.endPage1657.e7-
dc.identifier.bibliographicCitationJOURNAL OF INVESTIGATIVE DERMATOLOGY, Vol.139(8) : 1648-1657.e7, 2019-08-
Appears in Collections:
1. College of Medicine (의과대학) > BioMedical Science Institute (의생명과학부) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.